Skip to main content
logo
Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,335.00
+75.00 (3.32%)
At close: Aug 18, 2026

Green Lifescience Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
51,01740,34024,86122,36936,50525,338
Revenue Growth
119.98%62.26%11.14%-38.72%44.07%3.16%
Gross Profit
4,1462,4672,980-2,313-1,356-2,270
Operating Income
1,924204.29376.91-4,643-3,958-4,648
Net Income
3,011110.131,562-16,358-3,526-3,136
Earnings Per Share
155.325.7481.18-819.47-176.28-156.79
EPS Growth
--92.93%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
13,57317,18612,88514,45316,94916,203
Total Debt
5,2566,9925,3724,9336,6247,595
Net Cash (Debt)
8,31810,1947,5139,52010,3248,608
Net Cash Growth
15.78%35.68%-21.08%-7.79%19.93%-1.28%
Net Cash Per Share
429.11531.08390.48476.93516.22430.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,939363.85525.49370.02-4,552611.38
Capital Expenditures
-894.04-859.51-780.62-495.69-1,478-3,444
Free Cash Flow
-2,833-495.66-255.13-125.67-6,030-2,832
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
8.13%6.12%11.98%-10.34%-3.72%-8.96%
Operating Margin
3.77%0.51%1.52%-20.76%-10.84%-18.34%
Pretax Margin
5.90%0.27%6.28%-73.13%-7.84%-13.49%
Profit Margin
5.90%0.27%6.28%-73.13%-9.66%-12.38%
FCF Margin
-5.55%-1.23%-1.03%-0.56%-16.52%-11.18%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.03514.1620.54---
PS Ratio
0.891.401.291.992.445.98